The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 Testing

Ramy Arnaout, Rose Lee, Ghee Rye Lee, Cody Callahan, Annie Cheng, Christina Yen, Kenny Smith, Rohit Arora, James E. KirbyClinical 2020 · DOI

Abstract

The assay LoD meaningfully impacts clinical performance of SARS-CoV-2 tests. The highest LoDs on the market will miss a majority of infected patients. Assays should therefore be benchmarked against a universal standard to allow cross-comparison of SARS-CoV-2 detection methods.
BibTeX
@inproceedings{arnaout2020limit,
  author = {Ramy Arnaout and Rose Lee and Ghee Rye Lee and Cody Callahan and Annie Cheng and Christina Yen and Kenny Smith and Rohit Arora and James E. Kirby},
  title = {{The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 Testing}},
  booktitle = {Clinical},
  year = {2020},
  doi = {10.1093/cid/ciaa1382},
}

Loading related content...

Figure